Summit Therapeutics to Present at Upcoming Conferences
18 March 2019 - 10:00PM
Summit Therapeutics plc (‘Summit’ or the
‘Company’)
Summit Therapeutics to Present at Upcoming
Conferences
Oxford, UK, and Cambridge, MA, US, 18 March
2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a
leader in new mechanism antibiotic innovation, announces that
management will present at two upcoming conferences.
Details of the conference presentations:
- Superbugs & Superdrugs 2019: The Development of Precision
Antibiotics: Agents Designed to Meet the Demands of Stewardship, on
18 March 2019 at 1:40pm GMT in London
- Oppenheimer 29th Annual Healthcare Conference: corporate
presentation on 20 March 2019 at 2:10pm EDT in New York City
A live webcast of the Oppenheimer presentation
will be available in the Investors section of the Company's
website, www.summitplc.com. A replay of the webcast will be
available from the same location soon after the live
presentation.
About Summit Therapeutics Summit
Therapeutics is a leader in antibiotic innovation. Our new
mechanism antibiotics are designed to become the new standards of
care for the benefit of patients, and create value for payors and
healthcare providers. We are currently developing new mechanism
antibiotics for C. difficile infection and gonorrhoea and are using
our proprietary Discuva Platform to expand our pipeline. For more
information, visit www.summitplc.com and follow us on Twitter
@summitplc.
Contacts
Summit |
|
|
Glyn Edwards / Richard Pye (UK
office) |
Tel: |
44 (0)1235 443 951 |
Michelle Avery (US office) |
|
+1 617 225 4455 |
|
|
|
Cairn Financial Advisers LLP
(Nominated Adviser) |
Tel: |
+44 (0)20 7213 0880 |
Liam Murray / Tony Rawlinson |
|
|
|
|
|
N+1 Singer (Joint Broker) |
Tel: |
+44 (0)20 7496 3000 |
Aubrey Powell / Jen Boorer, Corporate
FinanceTom Salvesen, Corporate Broking |
|
|
|
|
|
Bryan Garnier & Co Limited
(Joint Broker) |
Tel: |
+44 (0)20 7332 2500 |
Phil Walker / Dominic Wilson
|
|
|
MSL Group (US) |
Tel: |
+1 781 684 6557 |
Jon Siegal |
|
summit@mslgroup.com |
|
|
|
Consilium Strategic Communications
(UK) |
Tel: |
+44 (0)20 3709 5700 |
Mary-Jane Elliott / Sue Stuart / Jessica
Hodgson / |
|
summit@consilium-comms.com |
Lindsey Neville |
|
|
-END-
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Jul 2023 to Jul 2024